2seventy bio's GAAP loss for 3 months of 2022 was $85.711 million, down 1.7% from $87.196 million in the prior year. Revenue decreased 29.2% to $8.429 million from $11.901 million a year earlier.
2seventy bio's GAAP loss for 3 months of 2022 was $85.711 million, down 1.7% from $87.196 million in the prior year. Revenue decreased 29.2% to $8.429 million from $11.901 million a year earlier. 
ir.2seventybio.com
English (US) 